Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
122 hedge funds and large institutions have $145M invested in Lumos Pharma, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 11 closing their positions.
398% more call options, than puts
Call options by funds: $13.3M | Put options by funds: $2.68M
164% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 11
17% more funds holding
Funds holding: 104 → 122 (+18)
3% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 36
28% less capital invested
Capital invested by funds: $202M → $145M (-$57.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.16M |
| 2 |
Millennium Management
New York
|
+$2.03M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.6M |
| 4 |
Morgan Stanley
New York
|
+$1.3M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HT
HAP Trading
New York
|
-$3.73M |
| 2 |
Renaissance Technologies
New York
|
-$2.52M |
| 3 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$1.9M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.79M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.18M |
LUMO Hedge Fund Activity: Q4 2016 in Review
122 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2016, worth a combined $145M — down 28% from $202M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new LUMO positions and 11 closed out — a net gain of 18 holders — while 37 added to existing stakes and 36 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $6.16M. The largest seller was HAP Trading, exiting entirely with an estimated $3.73M sold.
- 122 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2016, up from 104 in Q3 2016.
- Funds reported $145M of Lumos Pharma, Inc. Common Stock stock for Q4 2016, down 28% quarter-over-quarter.
- 29 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2016 and 11 closed out, a net change of +18 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2016 was Fidelity Investments, an estimated $6.16M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q4 2016 was HAP Trading, an estimated $3.73M sold.
Based on aggregated 13F filings for Q4 2016.